Soleus Capital Management, L.P. Penumbra Inc Transaction History

Soleus Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$172.27 - $223.95 $6.5 Million - $8.45 Million	37,750 Added 44.05%	123,450 $22.2 Million
Q1 2024 May 15, 2024	BUY	$220.09 - $273.15 $1.39 Million - $1.72 Million	6,300 Added 7.93%	85,700 $19.1 Million
Q4 2023 Feb 14, 2024	BUY	$181.44 - $260.22 $14.4 Million - $20.7 Million	79,400 New	79,400 $20 Million
Q4 2022 Feb 14, 2023	BUY	$151.88 - $228.5 $1.41 Million - $2.13 Million	9,300 New	9,300 $2.07 Million
Q2 2022 Aug 15, 2022	BUY	$116.09 - $227.33 $7.99 Million - $15.6 Million	68,800 New	68,800 $8.57 Million

373

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.11B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.